Table 9.
Secondary outcomes in patients with low back pain and degenerative disc randomised to disc prosthesis surgery or rehabilitation. Mean (SD) outcome values on EQ-5D, HSCL-25, FABQ, and self efficacy at follow-up and treatment effect (difference (95% confidence interval))
| Variable* | Surgery | Rehabilitation | Treatment effect† |
|---|---|---|---|
| EQ-5D‡ | |||
| Baseline | 0.30 (0.30) | 0.27 (0.31) | — |
| 6 weeks | 0.59 (0.30) | 0.55 (0.29) | 0.04 (−0.06 to 0.15) |
| 3 months | 0.70 (0.23) | 0.48 (0.31) | 0.22 (0.12 to 0.33) |
| 6 months | 0.68 (0.28) | 0.51 (0.33) | 0.17 (0.06 to 0.27) |
| 1 year | 0.67 (0.35) | 0.54 (0.32) | 0.13 (0.02 to 0.23) |
| 2 years | 0.68 (0.34) | 0.60 (0.30) | 0.08 (−0.03 to 0.18) |
| HSCL-25§ | |||
| Baseline | 1.81 (0.50) | 1.88 (0.51) | — |
| 3 months | 1.38 (0.34) | 1.66 (0.51) | −0.27 (−0.44 to −0.11) |
| 6 months | 1.44 (0.45) | 1.66 (0.49) | −0.22 (−0.38 to −0.05) |
| 1 year | 1.45 (0.50) | 1.59 (0.49) | −0.14 (−0.30 to 0.03) |
| 2 years | 1.47 (0.49) | 1.55 (0.50) | −0.09 (−0.25 to 0.08) |
| FABQ work§ | |||
| Baseline | 25.8 (11.2) | 27.4 (9.9) | — |
| 3 months | 20.0 (12.9) | 24.3 (11.9) | −4.3 (−8.6 to 0.1) |
| 6 months | 18.7 (12.9) | 23.0 (12.7) | −4.3 (−8.7 to 0.1) |
| 1 year | 18.2 (13.9) | 21.3 (13.2) | −3.1 (−7.4 to 1.2) |
| 2 years | 16.7 (13.5) | 18.5 (12.5) | −1.8 (−6.1 to 2.5) |
| FABQ physical§ | |||
| Baseline | 14.0 (5.8) | 12.5 (5.6) | — |
| 3 months | 8.8 (5.3) | 9.1 (6.3) | −0.3 (−2.4 to 1.7) |
| 6 months | 8.6 (6.3) | 9.3 (6.7) | −0.7 (−2.8 to 1.3) |
| 1 year | 8.0 (6.3) | 8.9 (5.8) | −0.8 (−2.9 to 1.2) |
| 2 years | 8.0 (6.0) | 8.3 (5.7) | −0.3 (−2.3 to 1.7) |
| Self efficacy‡ | |||
| Baseline | 3.4 (1.5) | 3.6 (1.6) | — |
| 3 months | 6.1 (2.3) | 5.0 (2.2) | 1.0 (0.2 to 1.9) |
| 6 months | 6.0 (2.6) | 5.6 (2.4) | 0.5 (−0.3 to 1.3) |
| 1 year | 6.4 (3.3) | 5.5 (2.5) | 0.9 (0.0 to 1.7) |
| 2 years | 6.2 (2.7) | 5.6 (2.7) | 0.5 (−1.4 to 2.8) |
*See tables 1 and 5 for score details.
†EQ-5D P<0.001, HSCL P<0.001, FABQ work P=0.057, FABQ physical P=0.548, self efficacy P=0.019 for trend in treatment effect over time.
‡Positive scores indicate larger improvement in outcome with surgery.
§Negative scores indicate larger improvement in outcome with surgery.